InvestSMART

Osteopore Limited (ASX: OSX) - Announcements

- Current share price for OSX : $0.004

ASX company news and announcements for Osteopore Limited (OSX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Osteopore Limited (OSX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Osteopore Limited (OSX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Osteopore Limited (OSX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Increased presence and commercial opportunities across SEA 8 Dec 2022 9:08AM $0.200 $0.004 fallen by 98%
$3 Activities Update Qtr Ending September 2022 and Appendix 4C 31 Oct 2022 9:26AM $0.205 $0.004 fallen by 98.05%
$3 Ceasing to be a substantial holder 5 Oct 2022 7:13PM $0.230 $0.004 fallen by 98.26%
$3 Change in substantial holding 5 Oct 2022 7:12PM $0.230 $0.004 fallen by 98.26%
$3 Chile Government and University co-fund Osteopore research 28 Sep 2022 11:10AM $0.220 $0.004 fallen by 98.18%
$3 More Osteopore Products Available on Prostheses List 28 Sep 2022 8:52AM $0.220 $0.004 fallen by 98.18%
$3 Half Yearly Report and Accounts 31 Aug 2022 6:49PM $0.285 $0.004 fallen by 98.60%
$3 Change in substantial holding 24 Aug 2022 7:06PM $0.260 $0.004 fallen by 98.46%
$3 Becoming a substantial holder 24 Aug 2022 7:05PM $0.260 $0.004 fallen by 98.46%
$3 Osteopore Moves Closer to China Market Entry 23 Aug 2022 9:35AM $0.220 $0.004 fallen by 98.18%
$3 Investor Presentation 10 Aug 2022 8:35AM $0.200 $0.004 fallen by 98%
$3 Osteopore Gains Access to US Federal Healthcare Facilities 3 Aug 2022 9:47AM $0.140 $0.004 fallen by 97.14%
$3 SHG: Clarification regarding collaboration with OSX 2 Aug 2022 12:04PM $0.140 $0.004 fallen by 97.14%
$3 SHG: Collaborative Agreement signed with OSX 1 Aug 2022 8:50AM $0.135 $0.004 fallen by 97.04%
$3 Osteopore to Leverage on AI/VR to Enhance Market Access 1 Aug 2022 7:53AM $0.135 $0.004 fallen by 97.04%
$3 Activities Update Qtr Ending June 2022 and Appendix 4C 25 Jul 2022 10:13AM $0.160 $0.004 fallen by 97.50%
$3 Notification of cessation of securities - OSX 4 Jul 2022 9:24AM $0.125 $0.004 fallen by 96.80%
$3 Change of Director's Interest Notice 1 Jul 2022 12:08PM $0.135 $0.004 fallen by 97.04%
$3 Collaboration With Healthcare Group To Develop New Products 20 Jun 2022 11:29AM $0.130 $0.004 fallen by 96.92%
$3 Change of Director's Interest Notice 15 Jun 2022 7:16PM $0.140 $0.004 fallen by 97.14%
$3 OSX Expands into Africa with Initial Sales to South Africa 14 Jun 2022 8:14AM $0.140 $0.004 fallen by 97.14%
$3 Constitution 1 Jun 2022 7:25PM $0.155 $0.004 fallen by 97.42%
$3 Employee Securities Incentive Plan 1 Jun 2022 7:23PM $0.155 $0.004 fallen by 97.42%
$3 Results of Annual General Meeting 31 May 2022 7:18PM $0.170 $0.004 fallen by 97.65%
$3 OSX Enter Oral & Maxillofacial Market in Australia & NZ 10 May 2022 9:50AM $0.180 $0.004 fallen by 97.78%

376 - 400 of 518 results

Page 16 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.